Literature DB >> 6212561

[Clinico-experimental studies on the effect of benzoylperoxide].

M Puschmann.   

Abstract

Clinical and experimental investigations to characterize therapeutic effects of topically applied benzoyl peroxide (5 and 10% in alcohol-free gel formulation) were performed with: quantitative determination of bacteria in the follicular filaments with the cyanoacrylate technique (P. acnes and micrococcaceae); agar diffusion method for bacteriostatic effects; semi-quantitative determination of skin surface lipids (ground glass method); lipid solvent and thin-layer chromatography (free fatty acids vs. triglycerides); scanning electron microscopy of the skin surface; exfoliative cytology with corneocyte counts in a Fuchs-Rosenthal chamber (corneocytes/cm2 skin surface); determination of corneocyte surface are in micrometer2; and a clinical trial concerning efficacy and tolerance of the gel formulation. Topically applied benzoyl peroxide acts antibacterially and keratolytically, has anti-lipolytic activity, reduces bacteria in the follicular infundibula, but does not inhibit sebum production as measured by skin surface lipids. Benzoyl peroxide stimulates the epidermopoiesis with reduction of corneocytes/cm2 from 87,400 +/- 29,000 to 36,000 +/- 19,000 (day 15 of treatment) with diminution in size of corneocytes from 1,018 micrometers2 +/- 74 to 865 micrometers2 +/- 65 vs. 832 micrometers2 +/- 85 (5% vs. 10% benzoyl peroxide). Alcohol-free gels of benzoyl peroxide are better tolerated by acne patients than those containing alcohol, in particular when combined with topical tretinoin (vitamin A acid) treatment.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6212561

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  4 in total

1.  Patterns of follicular sebum excretion rate during lifetime.

Authors:  G E Piérard; C Piérard-Franchimont; T Lê; C Lapière
Journal:  Arch Dermatol Res       Date:  1987       Impact factor: 3.017

Review 2.  Transdermal penetration of topical drugs used in the treatment of acne.

Authors:  Andrea Krautheim; Harald Gollnick
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

3.  Are therapeutic effects of antiacne agents mediated by activation of FoxO1 and inhibition of mTORC1?

Authors:  Bodo C Melnik; Gerd Schmitz
Journal:  Exp Dermatol       Date:  2013-07       Impact factor: 3.960

Review 4.  p53: key conductor of all anti-acne therapies.

Authors:  Bodo C Melnik
Journal:  J Transl Med       Date:  2017-09-19       Impact factor: 5.531

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.